T1	Disease 32 38	tumors 
T2	Gene_or_protein 92 98	PIK3CA 
T4	Gene_or_protein 137 143	PIK3CA 
T5	Limited_variation 137 157	PIK3CA - p.Glu542Lys 
T6	Chemical 187 197	crizotinib 
T7	Gene_or_protein 216 222	PIK3CA 
T8	Phenotype 48 76	high level MET amplification
T9	Limited_variation 216 234	PIK3CA co-mutation
T10	Pharmacodynamic_phenotype 250 267	clinical response
T12	Gene_or_protein 59 62	MET
T13	Limited_variation 82 98	wild-type PIK3CA
T14	Limited_variation 102 131	MET exon 14 skipping mutation
T3	Gene_or_protein 102 105	MET
T11	Pharmacodynamic_phenotype 174 197	responses to crizotinib
T15	Genomic_variation 59 76	MET amplification
T16	Genomic_factor 102 113	MET exon 14
R1	influences Arg1:T9 Arg2:T10	
R2	treats Arg1:T6 Arg2:T1	
R3	isAssociatedWith Arg1:T13 Arg2:T11	
R4	isAssociatedWith Arg1:T14 Arg2:T11	
R5	isAssociatedWith Arg1:T5 Arg2:T11	
R6	isAssociatedWith Arg1:T1 Arg2:T8	
#1	AnnotatorNotes R1	neg
